Culprits of Medication-Induced Telogen Effluvium, Part 1
Cutis · 2023
DOI: 10.12788/cutis.0910 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cutis, 2023. Verfasst von Donglin Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Telogen effluvium (TE) is a common clinical consequence of medication-related alopecia. The inciting cause of TE may be difficult to identify due to delays in clinically apparent hair loss. Because medication-induced TE is a nonscarring alopecia that typically is reversible, appropriate management requires identification of the underlying triggering medication and cessation of it, if possible. In part 1 of this series, we review the existing literature on medication-induced TE with a focus on systemic retinoids, antifungal agents, and psychotropic medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.
Zitieren
APA
Zhang, D., LaSenna, C., & Shields, B. E. (2023). Culprits of Medication-Induced Telogen Effluvium, Part 1. Cutis. https://doi.org/10.12788/cutis.0910
Vancouver
Zhang D, LaSenna C, Shields BE. Culprits of Medication-Induced Telogen Effluvium, Part 1. Cutis. 2023. doi:10.12788/cutis.0910
BibTeX
@article{Zhang2023,
author = {Zhang, Donglin and LaSenna, Charlotte and Shields, Bridget E},
title = {Culprits of Medication-Induced Telogen Effluvium, Part 1},
journal = {Cutis},
year = {2023},
doi = {10.12788/cutis.0910}
}
EUVIMED